You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中基長壽科學(00767.HK)擬攜手好柿多(深圳)共同合作長壽檢測、長壽管理等業務

格隆匯7月29日丨中基長壽科學(00767.HK)公告,於2025年7月29日,公司全資附屬公司浤烽發展有限公司("浤烽發展")與好柿多(深圳)生物科技有限公司("好柿多")訂立合作備忘錄,據此,浤烽發展與好柿多有意共同合作長壽檢測、長壽管理等業務,爲客戶提供長壽生物製品、長壽醫學檢測、健康諮詢服務、長壽管理等大健康產業產品及服務。

擬進行合作事項將包括浤烽發展負責提供產品服務及管理系統的支援,好柿多負責爲浤烽發展提供國內客戶資源及市場銷售管道。

公司爲於百慕達註冊成立的有限公司,爲一間投資控股公司,透過其附屬公司主要從事長壽科學業務、借貸與金融投資諮詢,以及證券、物業及投資業務。浤烽發展爲一家於香港成立的有限公司,主要從事長壽科學研發、轉化和應用,通過四大分部運營,長壽科學研究、長壽醫學檢測分部、長壽生物製品分部、長壽管理分部。浤烽發展擁有強大的健康領域資源及自研優質產品,包括自有長壽生物製品、長壽醫學檢測專案等核心產品,致力於讓人類健康的長壽。

董事會認爲健康長壽科學市場的前景廣闊,因爲觀察到全球的富裕客戶更願意接受及花費在長壽科學應用上,以提升彼等的整體健康及免疫狀況,並促進彼等身體年輕化。

訂立備忘錄符合集團長壽科學業務發展策略及計劃,將有利於集團未來的業務發展。董事會相信合作事項進一步完善集團在長壽科學診斷及醫療服務領域的佈局,爲公司開拓新的長壽科學收入來源,以期長遠爲集團帶來更加穩定及持續增長的收入。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account